These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
371 related items for PubMed ID: 15911330
1. Poly(ADP-ribosyl)ation and stroke. Chiarugi A. Pharmacol Res; 2005 Jul; 52(1):15-24. PubMed ID: 15911330 [Abstract] [Full Text] [Related]
2. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain. Tokime T, Nozaki K, Sugino T, Kikuchi H, Hashimoto N, Ueda K. J Cereb Blood Flow Metab; 1998 Sep; 18(9):991-7. PubMed ID: 9740102 [Abstract] [Full Text] [Related]
3. Mediation of cell death by poly(ADP-ribose) polymerase-1. Koh DW, Dawson TM, Dawson VL. Pharmacol Res; 2005 Jul; 52(1):5-14. PubMed ID: 15911329 [Abstract] [Full Text] [Related]
4. Poly(ADP-ribosyl)ation in asthma and other lung diseases. Virág L. Pharmacol Res; 2005 Jul; 52(1):83-92. PubMed ID: 15911336 [Abstract] [Full Text] [Related]
5. [Role of poly(ADP-ribosyl)ation in cell death]. Maruta H, Tanuma S. Seikagaku; 2005 Jun; 77(6):484-90. PubMed ID: 16022423 [No Abstract] [Full Text] [Related]
7. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia. Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S. J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382 [Abstract] [Full Text] [Related]
8. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies. Virág L. Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317 [Abstract] [Full Text] [Related]
9. Poly(ADP-ribosyl)ation polymerases: mechanism and new target of anticancer therapy. Heitz F, Harter P, Ewald-Riegler N, Papsdorf M, Kommoss S, du Bois A. Expert Rev Anticancer Ther; 2010 Jul; 10(7):1125-36. PubMed ID: 20645701 [Abstract] [Full Text] [Related]
11. Inhibition of telomerase activity by reduction of poly(ADP-ribosyl)ation of TERT and TEP1/TP1 expression in HeLa cells with knocked down poly(ADP-ribose) polymerase-1 (PARP-1) gene. Ghosh U, Das N, Bhattacharyya NP. Mutat Res; 2007 Feb 03; 615(1-2):66-74. PubMed ID: 17141279 [Abstract] [Full Text] [Related]
12. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats. Nakajima H, Kakui N, Ohkuma K, Ishikawa M, Hasegawa T. J Pharmacol Exp Ther; 2005 Feb 03; 312(2):472-81. PubMed ID: 15466246 [Abstract] [Full Text] [Related]
13. Effect of zinc on cellular poly(ADP-ribosyl)ation capacity. Kunzmann A, Dedoussis G, Jajte J, Malavolta M, Mocchegiani E, Bürkle A. Exp Gerontol; 2008 May 03; 43(5):409-14. PubMed ID: 18022337 [Abstract] [Full Text] [Related]
14. Poly(ADP-ribose) metabolism in brain and its role in ischemia pathology. Strosznajder RP, Czubowicz K, Jesko H, Strosznajder JB. Mol Neurobiol; 2010 Jun 03; 41(2-3):187-96. PubMed ID: 20411356 [Abstract] [Full Text] [Related]